St. Jude Medical Inc. announced that the FDA cleared the ACross Transseptal Access System, a device designed to improve control and simplify the procedure physicians use to access the left atrium during complex cardiac procedures such as atrial fibrillation ablation.
September 6, 2007 - While few complications were found last year with implantable cardioverter defibrillators (ICDs), 15 ...
GE Healthcare has released the latest version of Centricity Enterprise, an intelligent and integrated software suite of clinical and financial applications that is designed to improve patient care and increase collaboration between clinicians, providing a better overall healthcare environment.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Siemens Automation and Drives (A&D) has added a 1MP color display to its portfolio of medical monitors. The SCD 19110 ...
September 5, 2007 – According to Boston Scientific Corp., results from the TAXUS WOMAN study, a gender specific analysis ...
Cordis Endovascular announced, at the 61st Annual Meeting of the Society for Vascular Surgery, the worldwide launch of ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Guerbet’s flagship X-ray contrast agent, Oxilan (ioxilan) injection, is a contrast agent that is a nonionic, low-viscous ...
September 6, 2007 – Boston Scientific Corp. announced at the ESC 2007 conference in Vienna, Austria, that results from ...
September 5, 2007 - Results from a study on acute cardiogenic pulmonary edema, or "fluid on the lung," presented at the ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 5, 2007 - Clinical investigators at the European Society of Cardiology Congress 2007 (ESC Congress 2007) ...
September 5, 2007 - The National Institutes of Health has awarded its $5 million Bioengineering Research Partnership ...
September 5, 2007 - Edwards Lifesciences Corp. announced that it has received CE Mark approval for European commercial ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 4, 2007- New recommendations released today in the Journal of the American Society of Echocardiography further support the role of stress echo in accurately identifying coronary artery disease (CAD), determining prognosis of patients with known or suspected CAD, in addition to providing recommendations for optimizing imaging.
September 4, 2007 - Analysis of clinical trials showed the Cypher Sirolimus-eluting coronary stent was associated with ...
September 4, 2007 – At the European Society of Cardiology’s (ESC) annual congress, Royal Philips Electronics ...
September 05, 2007
